Victoza Side Effects
Links shared publicly online about this topic
Victoza never mind the side effects | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Victoza never mind the side effects | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on February 4, 2010 at 1:59 pm By:
Victoza never mind the side effects http://tinyurl.com/yz262ok - Keyvive
Victoza More Effective Than Competitors New Study Shows | A Sweet Life
asweetlife.org — “Victoza reductions were followed by insulin glargine (Lantus) and exenatide (Byetta). Patients taking Januvia (sitagliptin) experienced no reduction to 1.1%.” View full resource at asweetlife.org
Most Recently Shared on April 15, 2011 at 8:50 pm By:
From asweetlife.org: Victoza More Effective Than Competitors New Study Shows , data presented at #AACE11 http://bit.ly/fw9h5d
Pharmacy Europe - Victoza more effective at lowering blood sugar
pharmacyeurope.net — “Pharmacy europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at pharmacyeurope.net
Most Recently Shared on June 9, 2009 at 7:12 pm By:
Victoza more effective at lowering blood sugar - http://tinyurl.com/nl89od
Novo's Victoza beats Merck drug in diabetes study | Reuters
reuters.com — “LONDON (Reuters) - Novo Nordisk's new diabetes drug Victoza proved more effective than Merck & Co's Januvia in a head-to-head study, boosting prospects for a product that has got off to a strong start” View full resource at reuters.com
Most Recently Shared on April 22, 2010 at 11:38 pm By:
HealthIT Policy Health News and Health IT
Novo's Victoza beats Merck drug in diabetes study: LONDON (Reuters) - Novo Nordisk's new diabetes drug Victoza pro... http://bit.ly/dyZffl
Novo's Victoza beats Merck drug in diabetes study | Reuters
reuters.com — “LONDON (Reuters) - Novo Nordisk's new diabetes drug Victoza proved more effective than Merck & Co's Januvia in a head-to-head study, boosting prospects for a product that has got off to a strong start” View full resource at reuters.com
Most Recently Shared on April 22, 2010 at 11:38 pm By:
Novo's Victoza beats Merck drug in diabetes study: LONDON (Reuters) - Novo Nordisk's new diabetes dru... http://bit.ly/9bz7L7 #health #news
UPDATE: Novo Nordisk's Victoza Has Good Early Type 2 Effect -Study - WSJ.com
online.wsj.com — “UPDATE: Novo Nordisk's Victoza Has Good Early Type 2 Effect -Study - WSJ.com” View full resource at online.wsj.com
Most Recently Shared on September 13, 2011 at 5:17 pm By:
Drugs and Devices OW OW Health
Novo Nordisk's Victoza Has Good Early Type 2 Effect -Study - Wall Street Journal: InPharmNovo Nordisk's Vi... http://t.co/8r0R7pD #drug
Novo Nordisk Partners With International Scientific Community For Victoza® Cardiovascular Outcomes Trial
medicalnewstoday.com — “Novo Nordisk announced details of the company's cardiovascular outcomes trial for Victoza® (liraglutide) which is set to start in the autumn of 2010.The trial named LEADER™ (Lir” View full resource at medicalnewstoday.com
Most Recently Shared on June 1, 2010 at 3:09 pm By:
MNT Cardiovascular Health News
Novo Nordisk Partners With International Scientific Community For Victoza® Cardiovascular Outcomes Trial http://mnt.to/3DkH
Novo Nordisk's Victoza(R) Receives FDA Approval For Adults With Type 2 Diabetes
medicalnewstoday.com — “Novo nordisk (nvo) announced that the u.s. food and drug administration (fda) approved the new drug application for victoza® (liraglutide [rdna origin] injection), the first once-daily human g” View full resource at medicalnewstoday.com
Most Recently Shared on January 27, 2010 at 4:08 pm By:
Novo Nordisk's Victoza(R) Receives FDA Approval For Adults With Type 2 Diabetes http://mnt.to/3wPq #diabetes
Novo Nordisk Partners With International Scientific Community For Victoza(R) Cardiovascular Outcomes Trial
medicalnewstoday.com — “Novo Nordisk (NVO) announced details of the company's cardiovascular outcomes trial for Victoza® (liraglutide [rDNA origin] injection), which is set to start in the autumn of 2010.The” View full resource at medicalnewstoday.com
Most Recently Shared on May 12, 2010 at 12:42 pm By:
MedicalNewsToday: Novo Nordisk Partners With International Scientific Community For: http://bit.ly/bmmjeM Full http://bit.ly/a0ApOd
NICE gives Novo's Victoza expanded nod - FiercePharma
fiercepharma.com — “Novo Nordisk got a boost from the U.K.'s National Institute for Health and Clinical Excellence. The company's new diabetes drug Victoza got the cost-effectiveness watchdog's blessing for broader use... Read more...” View full resource at fiercepharma.com
Most Recently Shared on June 14, 2010 at 3:27 pm By:
NICE gives Novo's Victoza expanded nod. http://bit.ly/brZfGk
Novo's Victoza beats Merck drug in diabetes study - Yahoo! News
news.yahoo.com — “Novo Nordisk's new diabetes drug Victoza proved more effective than Merck & Co's Januvia in a head-to-head study, boosting prospects for a product that has got off to a strong start in key markets.” View full resource at news.yahoo.com
Most Recently Shared on April 22, 2010 at 11:15 pm By:
Novo's Victoza beats Merck drug in diabetes study (Reuters) http://bit.ly/aInrtO
GLP-1 analog outperforms sulfonylurea in type 2 diabetes
theheart.org — “In a head-to-head comparison, liraglutide reduced A1C levels more effectively with virtually no hypoglycemia and with weight loss, compared with weight gain with glimepiride.” View full resource at theheart.org
Most Recently Shared on June 15, 2009 at 6:05 pm By:
heartwire: GLP-1 inhibitor outperforms sulfonylurea in type 2 diabetes http://bit.ly/vgZEm
Medical News: AACE: No Antibody Problems with Liraglutide - in Meeting Coverage, AACE from MedPage Today
medpagetoday.com — “BOSTON -- Few patients develop antibodies to liraglutide (Victoza), and the drug's therapeutic effects aren't blunted in those who do, researchers said here.” View full resource at medpagetoday.com
Most Recently Shared on April 26, 2010 at 7:07 pm By:
No antibody problems with liraglutide #AACE10 http://bit.ly/aFKzOv
Medical News: ADA: Diabetes Drug May Help Others Lose Weight - in Meeting Coverage, ADA from MedPage Today
medpagetoday.com — “SAN DIEGO -- The diabetes drug liraglutide (Victoza), touted for its weight-loss effects in that patient population, may also help non-diabetic patients keep pounds off, researchers said here.” View full resource at medpagetoday.com
Most Recently Shared on June 26, 2011 at 8:04 pm By:
ADA: Diabetes Drug May Help Others Lose Weight (CME/CE) http://bit.ly/jhHuBL
Diovan HCT Side Effects
drugs.com — “Comprehensive and accurate Diovan HCT side effects information for consumers and healthcare professionals.” View full resource at drugs.com
Most Recently Shared on February 19, 2010 at 7:26 pm By:
Renal insufficiency as a side effect of Diovan - Get more information. http://bit.ly/chXaW6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Aimee Greenholtz
Diabetes Care. Helping people with diabetes succeed in leading a healthy life.
-
AACE
The official Twitter account for the American Association of Clinical Endocrinologists (AACE).
-
Jim
Editor of Glycosmedia
Advertisement
